TY  - GEN
AU  - Leinhase,Iris
AU  - Schmidt,Oliver I
AU  - Thurman,Joshua M
AU  - Hossini,Amir M
AU  - Rozanski,Michal
AU  - Taha,Mohy E
AU  - Scheffler,Alice
AU  - John,Thilo
AU  - Smith,Wade R
AU  - Holers,V Michael
AU  - Stahel,Philip F
TI  - Pharmacological complement inhibition at the C3 convertase level promotes neuronal survival, neuroprotective intracerebral gene expression, and neurological outcome after traumatic brain injury
SN  - 0014-4886
PY  - 2006///0811
KW  - Animals
KW  - Behavior, Animal
KW  - drug effects
KW  - Blotting, Western
KW  - methods
KW  - Brain
KW  - Brain Injuries
KW  - drug therapy
KW  - Cell Survival
KW  - Complement System Proteins
KW  - genetics
KW  - Disease Models, Animal
KW  - Gene Expression
KW  - Immunohistochemistry
KW  - Male
KW  - Mice
KW  - Mice, Inbred C57BL
KW  - Neurons
KW  - Neuroprotective Agents
KW  - administration & dosage
KW  - Proto-Oncogene Proteins c-bcl-2
KW  - Psychomotor Performance
KW  - RNA, Messenger
KW  - metabolism
KW  - Receptors, Complement
KW  - Receptors, Complement 3b
KW  - Reverse Transcriptase Polymerase Chain Reaction
KW  - Time Factors
KW  - Trauma Severity Indices
N1  - Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.expneurol.2006.01.033
ER  -